2003
DOI: 10.1016/j.clim.2003.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Amelioration of graft versus host disease by galectin-1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
114
1
9

Year Published

2007
2007
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 119 publications
(134 citation statements)
references
References 44 publications
6
114
1
9
Order By: Relevance
“…Our observations regarding Gal1 function in cHL are consistent with reports regarding the role of the lectin in murine models of Th1-driven chronic inflammatory and autoimmune disorders, including collagen-induced arthritis, inflammatory bowel disease, graft vs. host disease, and autoimmune uveitis (17)(18)(19)(20). In these studies, the administration of Gal1 dramatically suppressed Th1-dependent responses and skewed toward Th2 cytokine profiles (17)(18)(19)(20)29).…”
Section: Discussionsupporting
confidence: 80%
See 2 more Smart Citations
“…Our observations regarding Gal1 function in cHL are consistent with reports regarding the role of the lectin in murine models of Th1-driven chronic inflammatory and autoimmune disorders, including collagen-induced arthritis, inflammatory bowel disease, graft vs. host disease, and autoimmune uveitis (17)(18)(19)(20). In these studies, the administration of Gal1 dramatically suppressed Th1-dependent responses and skewed toward Th2 cytokine profiles (17)(18)(19)(20)29).…”
Section: Discussionsupporting
confidence: 80%
“…In these studies, the administration of Gal1 dramatically suppressed Th1-dependent responses and skewed toward Th2 cytokine profiles (17)(18)(19)(20)29). A careful examination of the mechanisms involved in Gal1-mediated Th2 skewing recently revealed that Th1 cells express the repertoire of cell surface glycans required for Gal1 binding and subsequent cell death, whereas Th2 cells are protected from Gal1 by differential sialylation of their cell surface glycoproteins (30).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Its up-regulation in tumors correlates with poor clinical outcome, possibly because galectin-1 reduces the survival of tumor resident T cells and promotes tumor immune escape (19). In addition, galectin-1 has been implicated in transplantation tolerance because it diminishes morbidity and mortality of graft-versus-host disease in a mouse allogeneic bone marrow transplantation model (20).Galectin-1 is up-regulated in uterine natural killer cells and is a key moderator of regulatory T cell functions (21,22). A recent study reported that galectin-1 induces the generation of tolerogenic dendritic cells and regulatory T cells in mice, and the knockout of LGALS1 led to a higher rate of fetal loss in allogeneic mating (9).…”
mentioning
confidence: 99%
“…Clinical ocular pathology can also be prevented by the administration of recombinant Galectin-1 (rGal-1) either early or late during the course of EAU. Galectin-1 is a member of a highly conserved protein family (25) , expressed at sites of T-cell activation and immune privilege (26)(27) , and has the potential to regulate inflammatory responses (28)(29)(30)(31)(32)(33)(34) . The treatment with rGal-1 in IRBP-induced EAU in B10.RIII mice resulted in significant amelioration of ocular inflammation.…”
Section: New Therapies In Eaumentioning
confidence: 99%